259 related articles for article (PubMed ID: 3028639)
1. Hepatitis BeAg in chronic asymptomatic hepatitis B surface antigen carriers and in primary hepatocellular carcinoma patients.
Tswana SA
Cent Afr J Med; 1986 May; 32(5):113-6. PubMed ID: 3028639
[No Abstract] [Full Text] [Related]
2. Hepatocellular carcinoma in hepatitis B surface antigen carriers in eight institutions.
Lohiya GS; Pirkle H; Nguyen H; Lohiya S; Vuu T
West J Med; 1988 Apr; 148(4):426-9. PubMed ID: 2838975
[TBL] [Abstract][Full Text] [Related]
3. Mutation "hot spot" in HLA class I-restricted T cell epitope on hepatitis B surface antigen in chronic carriers and hepatocellular carcinoma.
Chen WN; Oon CJ
Biochem Biophys Res Commun; 1999 Sep; 262(3):757-61. PubMed ID: 10471398
[TBL] [Abstract][Full Text] [Related]
4. A case/control study of hepatitis B virus serologic markers in Senegalese patients suffering from primary hepatocellular carcinoma.
Coursaget P; Maupas P; Goudeau A; Chiron JP; Raynaud B; Drucker J; Barin F; Denis F; Diop Mar I; Diop B
Prog Med Virol; 1981; 27():49-59. PubMed ID: 6262871
[No Abstract] [Full Text] [Related]
5. Prevalence of HBe-Ag and anti-HBe in asymptomatic HBs-Ag carriers and patients with liver disease.
Shanmugam J; Balakrishnan V; Thomas M; Jayaprakash PA
Indian J Pathol Microbiol; 1983 Jan; 26(1):1-5. PubMed ID: 6315579
[No Abstract] [Full Text] [Related]
6. Hepatitis B viral infection: part I. Clinical features.
Dzik WH; Alter HJ
Am Fam Physician; 1982 Aug; 26(2):119-26. PubMed ID: 6285684
[TBL] [Abstract][Full Text] [Related]
7. Incidences of HBeAg and anti-HBe in, and clinical course of hepatitis B virus carriers.
Tsuchie H; Kurimura O; Tamura I; Shimase K; Kaneto E; Kurimura T; Tsuda F; Mayumi M
Biken J; 1984 Dec; 27(4):169-76. PubMed ID: 6100353
[TBL] [Abstract][Full Text] [Related]
8. Primary hepatocellular carcinoma with hepatitis B virus infection in a 16-year-old noncirrhotic patient.
Gasser RW; Judmaier G; Zur Nedden D; Aufschnaiter M; Hofstaedter F
Am J Gastroenterol; 1983 May; 78(5):305-8. PubMed ID: 6189392
[TBL] [Abstract][Full Text] [Related]
9. [HBsAg carrier state and primary hepatocellular carcinoma--a ten-year prospective study].
Lu JH
Zhonghua Yu Fang Yi Xue Za Zhi; 1988 Sep; 22(5):259-62. PubMed ID: 2853039
[No Abstract] [Full Text] [Related]
10. The detection of alpha-fetoprotein in HBs Ag and HBe Ag carriers.
Panoyotopoulos S; Yiannacopoulos T; Margari-Papanicolaou P; Christou A
Allergol Immunopathol (Madr); 1982; 10(1):1-4. PubMed ID: 6177229
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of hepatitis B viral markers in hepatitis B endemic areas of China.
Luo S; Ye FS; Mo ZC; Su YX; He JS; Zhou CQ; Tong MJ; Henderson BE; Yu MC
Chin Med J (Engl); 1988 Sep; 101(9):654-8. PubMed ID: 2466618
[No Abstract] [Full Text] [Related]
12. [HBeAg and anti-HBe in asymptomatic carriers of HBsAg and in various forms of hepatitis and liver cirrhosis].
Kalinowska B; Nazarewicz-de Mezer T; Krawczyński K
Przegl Epidemiol; 1984; 38(3):249-56. PubMed ID: 6528039
[No Abstract] [Full Text] [Related]
13. The relationship of hepatitis B e antigen, DNA polymerase activity, and titer of hepatitis B surface antigen with ongoing liver injury in chronic hepatitis B virus infection.
Perrillo R; Campbell C; Wellinghoff W; Gelb L
Am J Gastroenterol; 1982 Jul; 77(7):445-9. PubMed ID: 7091131
[TBL] [Abstract][Full Text] [Related]
14. [Long-term course in asymptomatic carriers of HBsAg in an area of low prevalence of hepatocarcinoma].
Jmelnitzky A; Basualdo JA; Castelletto R; Mon JC; Belloni P; Rondina A; García C
Acta Gastroenterol Latinoam; 1989; 19(1):21-30. PubMed ID: 2481374
[TBL] [Abstract][Full Text] [Related]
15. Effect of cytotoxic chemotherapy on hepatitis B viral markers in patients with hepatocellular carcinoma.
Zaman S; Melia W; Johnson P; White Y; Williams R
Clin Oncol; 1984 Sep; 10(3):247-52. PubMed ID: 6090048
[TBL] [Abstract][Full Text] [Related]
16. Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis.
Huo TI; Wu JC; Lee PC; Chau GY; Lui WY; Tsay SH; Ting LT; Chang FY; Lee SD
Hepatology; 1998 Jul; 28(1):231-6. PubMed ID: 9657117
[TBL] [Abstract][Full Text] [Related]
17. [Hepatitis B vaccines. An evaluation of human plasma extracted vaccines].
Prince AM; Vnek J
Fortschr Med; 1982 Oct; 100(40):1839-43. PubMed ID: 6293948
[No Abstract] [Full Text] [Related]
18. [Matched prospective study on chronic HBsAg carriers and primary hepatocellular cancer].
Lu JH
Zhonghua Zhong Liu Za Zhi; 1983 Nov; 5(6):406-8. PubMed ID: 6327215
[No Abstract] [Full Text] [Related]
19. Prevalence of hepatitis B virus and primary hepatocellular carcinoma in Asia.
Obata H; Nishioka K
Southeast Asian J Trop Med Public Health; 1979 Dec; 10(4):621-6. PubMed ID: 94184
[No Abstract] [Full Text] [Related]
20. [Hepatitis Bs antigen in primary liver cancer].
Kunchev K
Vutr Boles; 1978; 17(2):24-7. PubMed ID: 207025
[No Abstract] [Full Text] [Related]
[Next] [New Search]
